Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hellgren

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Intensive Care Medicine|January 1, 1984
Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patientsM Hellgren, N Egberg, J Eklund
Vardfacket|November 10, 1988
[Assessment in practice--we read films ourselves. Interview by Britta Nilsson]M Hellgren, H Eliassen, E Gustavsson
International Journal of Obstetric Anesthesia|May 23, 2021
Factor XIII activity at onset of labour and association with postpartum haemorrhage: an exploratory post-hoc studyO Karlsson, A Jeppsson, M Hellgren
Plant Physiology|May 4, 2004
Patterns of auxin distribution during gravitational induction of reaction wood in poplar and pineJenny M Hellgren, Kjell Olofsson, Björn Sundberg
Pregnancy Hypertension|June 25, 2015
PP107. Cardiovascular parameters 40 years after hypertensive pregnanciesM Hellgren, A-C Collen, K Manhem
American Journal of Obstetrics and Gynecology|July 1, 1995
Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptivesM Hellgren, P J Svensson, B Dahlbäck
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1982
Antithrombin III in late pregnancyM Hellgren, E B Nygårds, H Robbe
Thrombosis Research|August 15, 1984
Antithrombin III concentrate as adjuvant in DIC treatment. A pilot study in 9 severely ill patientsM Hellgren, L Javelin, K Hägnevik, et al.
Gynecologic and Obstetric Investigation|February 15, 2000
The incidence of pregnancy rhinitisE Ellegård, M Hellgren, K Torén, et al.
Maturitas|March 10, 2009
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesteroneM Hellgren, J Conard, L Norris, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Intensive Care Medicine|January 1, 1984
Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patientsM Hellgren, N Egberg, J Eklund
Vardfacket|November 10, 1988
[Assessment in practice--we read films ourselves. Interview by Britta Nilsson]M Hellgren, H Eliassen, E Gustavsson
International Journal of Obstetric Anesthesia|May 23, 2021
Factor XIII activity at onset of labour and association with postpartum haemorrhage: an exploratory post-hoc studyO Karlsson, A Jeppsson, M Hellgren
Plant Physiology|May 4, 2004
Patterns of auxin distribution during gravitational induction of reaction wood in poplar and pineJenny M Hellgren, Kjell Olofsson, Björn Sundberg
Pregnancy Hypertension|June 25, 2015
PP107. Cardiovascular parameters 40 years after hypertensive pregnanciesM Hellgren, A-C Collen, K Manhem
American Journal of Obstetrics and Gynecology|July 1, 1995
Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptivesM Hellgren, P J Svensson, B Dahlbäck
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1982
Antithrombin III in late pregnancyM Hellgren, E B Nygårds, H Robbe
Thrombosis Research|August 15, 1984
Antithrombin III concentrate as adjuvant in DIC treatment. A pilot study in 9 severely ill patientsM Hellgren, L Javelin, K Hägnevik, et al.
Gynecologic and Obstetric Investigation|February 15, 2000
The incidence of pregnancy rhinitisE Ellegård, M Hellgren, K Torén, et al.
Maturitas|March 10, 2009
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesteroneM Hellgren, J Conard, L Norris, et al.
Pageof 7